Medosome Biotec

Executive Summary

Medosome Biotec, LLC is a private US biotechnology company headquartered in Gainesville, Florida, founded in 2015. The company focuses on developing innovative therapies for pediatric rare and tropical diseases, leveraging precision medicine principles including genetic testing for diagnosis and personalized drug dosing. By integrating biologics and small molecules, Medosome aims to address significant unmet medical needs in underserved patient populations. Despite its niche focus, the company remains early-stage with no disclosed funding, valuation, or commercial products. Its progress depends on advancing preclinical or clinical programs, securing partnerships, and obtaining regulatory support. The precision medicine approach offers differentiation but also requires substantial validation and investment.

Upcoming Catalysts (preview)

• Q2 2026Announcement of lead program advancement to IND-enabling studies40% success
• H2 2026Strategic partnership or licensing deal for a pediatric rare disease asset30% success
• Q3 2026Grant funding or orphan drug designation from FDA for a tropical disease candidate50% success